Company news
Neuronetics, Inc. news in 2020
Neuronetics, Inc.'s news releases, calls and decks from 2020, newest first.
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
December 7, 2020
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
November 22, 2020
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
November 1, 2020
Neuronetics Appoints Sara Grubbs as Vice President, Sales
October 4, 2020
NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month
September 30, 2020
Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS
September 28, 2020
Neuronetics Reports Second Quarter 2020 Financial and Operating Results
August 3, 2020
Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer
July 13, 2020
Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors
June 25, 2020
Neuronetics, Inc. Announces Virtual 2020 Annual Meeting of Stockholders
May 11, 2020
Neuronetics Reports First Quarter 2020 Financial and Operating Results
May 4, 2020
Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan
April 7, 2020
Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System
March 15, 2020
FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression
March 5, 2020
Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO
March 4, 2020
Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
March 2, 2020
Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
January 20, 2020